Dihydralazine

This classification denotes an antihypertensive agent and hydrazine with the molecular formula C8H10N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PCU411F5L6, chemically known as 2,3-dihydro-1,4-phthalazinedione dihydrazone but generally known as dihydralazine, which bears US NIH Compound Identifier 10230. European Medicines Agency schedules Dihydralazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07137MIG. World Health Organization schedules dihydralazine in its Anatomical Therapeutic Chemical (ATC) Classification. DIHYDRALAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dihydralazine under HS 29339990 and SITC 51577. As of Q4 2014, DIHYDRALAZINE remains the US FDA Preferred Term for this commodity. Dihydralazine bears US NLM identifiers UMLS ID C0012271 and NCI Concept Code C97307. SMILES: n1nc(NN)c2c(c1NN)cccc2.